This compound is a protected morpholino cytosine monomer intermediate specifically designed for oligonucleotide synthesis. Its structure features a trityl-protected morpholino ring and a benzamide-protected cytosine base, making it suitable for solid-phase synthesis of morpholino phosphorodiamidate oligomers.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 125515-31-3
Tert-butyl 4-(phenylamino)piperidine-1-carboxylate
Pharmaceutical intermediate for drug synthesis
N1-(5-Chloro-2-pyridinyl)-N2-((1S,2R,4R)-4-((dimethylamino)carbonyl)-2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)ethanediamide
Pharmaceutical intermediate for edoxaban
1-[2-[2-[2-[2-[2-[2-[2-(2-bromoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-methoxyethane
polyethylene glycol linker intermediate
Tert-Butyl 4-amino-3,3-difluoropiperidine-1-carboxylate
Boc-protected aminofluoropiperidine intermediate
(6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate)
Oligonucleotide synthesis building block
N-[1-[(2R,6S)-6-(hydroxymethyl)-4-tritylmorpholin-2-yl]-2-oxopyrimidin-4-yl]benzamide
DMFVVKPXZHMPKX-XDFJSJKPSA-N
C1[C@H](O[C@H](CN1C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)N5C=CC(=NC5=O)NC(=O)C6=CC=CC=C6)CO
—